GeneQuine Biotherapeutics GmbH: Funding, Investors & Team (Sep 2026)
GeneQuine Biotherapeutics designs and develops gene therapies for its clients. The therapies developed by the company aim to treat osteoarthritis. Its product portfolio consists of GQ-201, GQ-202, and GQ-203. GeneQuine Biotherapeutics was founded in 2011 by Stanislav Plutizki and Kilian Guse.
GeneQuine Biotherapeutics GmbH has raised $6.6M across 1 funding round on record, the most recent a Series A of $6.6M announced in Feb 2021.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
GeneQuine Biotherapeutics GmbH Company Profile and Key Stats
Latest funding round on record: Feb 2021.
GeneQuine Biotherapeutics GmbH Funding Rounds
GeneQuine Biotherapeutics GmbH Founders and Leadership Team
Contact details for the GeneQuine Biotherapeutics GmbH team: 1 of 1 has an email address on file.
Start 14-day free trial →GeneQuine Biotherapeutics GmbH Funding Compared to Other Biotechnology Startups
GeneQuine Biotherapeutics GmbH's latest round of $6.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like GeneQuine Biotherapeutics GmbH in Biotechnology and Hamburg
Companies Similar to GeneQuine Biotherapeutics GmbH
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
GeneQuine Biotherapeutics GmbH Funding FAQs
What does GeneQuine Biotherapeutics GmbH do?
GeneQuine Biotherapeutics designs and develops gene therapies for its clients. The therapies developed by the company aim to treat osteoarthritis. Its product portfolio consists of GQ-201, GQ-202, and GQ-203. GeneQuine Biotherapeutics was founded in 2011 by Stanislav Plutizki and Kilian Guse.
How much funding has GeneQuine Biotherapeutics GmbH raised?
GeneQuine Biotherapeutics GmbH has raised $6.6M across 1 round on record. The most recent is a Series A of $6.6M announced in Feb 2021.
When did GeneQuine Biotherapeutics GmbH last raise funding?
GeneQuine Biotherapeutics GmbH's most recent funding round on record is a Series A of $6.6M, announced in Feb 2021.
Who is the CEO of GeneQuine Biotherapeutics GmbH?
Kilian Guse is listed as CEO at GeneQuine Biotherapeutics GmbH.
Where is GeneQuine Biotherapeutics GmbH headquartered?
GeneQuine Biotherapeutics GmbH is based in Hamburg, Germany.
How many employees does GeneQuine Biotherapeutics GmbH have?
GeneQuine Biotherapeutics GmbH is in the 1-10 employee band.
How does GeneQuine Biotherapeutics GmbH's funding compare to other Biotechnology startups?
GeneQuine Biotherapeutics GmbH's latest round of $6.6M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's GeneQuine Biotherapeutics GmbH Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for GeneQuine Biotherapeutics GmbH is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.